Introduction
NF-kB belongs to the Rel family of transcription factors that regulate a broad array of basic processes, including immune and proinflammatory responses, lymphoid organ development, cell growth and differentiation, malignant transformation and cell survival (reviewed in Karin and Ben-Neriah, 2000; Baldwin, 2001; BenNeriah, 2001; Lin and Karin, 2003) . In most cases, the transcriptional regulator is a dimer composed of various combinations of Rel A (p65), Rel B, c-Rel, p50 or p52. There are several levels of regulation of NF-kB. The first involves ubiquitin-mediated generation of the mature p50 and p52 subunits from their respective larger precursors p105 and p100 (Fan and Maniatis, 1991; Palombella et al., 1994; Orian et al., 1995; Fong and Sun, 2002) .
Processing of p105 is mostly constitutive. Following its generation, p50 associates with p65 and retained sequestered in the cytosol of quiescent cells, through interaction with a member of the IkB family of the inhibitory proteins (Karin and Ben-Neriah, 2000; Baldwin, 2001; Ben-Neriah, 2001; Lin and Karin, 2003) . Upon stimulation by diverse cellular signals, the IKK complex is activated and phosphorylates IkBs on specific serine residues. This leads to their rapid polyubiquitination by the SCF b-TrCP ubiquitin ligase followed by proteasomal degradation. Signaling leads also to IKKb-catalysed phosphorylation of the C-terminal domain of p105, TrCP-mediated ubiquitination and rapid degradation/ processing of the precursor (Heissmeyer et al., 1999; Orian et al., 2000) . However, signal-induced processing/ degradation of p105 does not appear to play a major role in p50 generation, as processing is mostly constitutive and the mechanisms involved in it have remained obscure. Following degradation of IkBs, NF-kB is translocated into the nucleus where it activates various genes (Karin and Ben-Neriah, 2000) . This has been termed the canonical NF-kB activation pathway.
While processing of p105 is mostly constitutive, processing of p100 is tightly regulated and is essential for development and maturation of lymphoid organs. Lack of constitutive processing of p100 is attributed to its C-terminal death domain (DD) that functions as a processing-inhibitory domain (PID). Active processing of p100 is induced by a noncanonical signaling pathway mediated by NIK and IKKa (Senftleben et al., 2001; Xiao et al., 2001) . In resting cells, Rel B is associated with p100 in the cytoplasm (Lin and Karin, 2003) . Following NIK activation, IKKa phosphorylates p100 at the C-terminal serine residues 865 and 869, leading to recruitment of the SCF b-TrCP ubiquitin ligase, rapid polyubiquitination and subsequent proteasome-mediated processing (Fong and Sun, 2002) . Following processing and association with Rel B, NF-kB2 is translocated into the nucleus. It is not known to be further regulated by binding to IkBs (Lin and Karin, 2003) . It should be noted that the phosphorylation site of IKKa in p100 is similar to the common recognition motif of the SCF b-TrCP ubiquitin ligase found in IkBa, IkBb, IkBe, b-catenin and HIV-Vpu, where the two phosphorylated serines are interspaced by three residues (Karin and Ben-Neriah, 2000) .
NEDD8 is a mammalian member of the ubiquitin-like (UBL) family of proteins. NEDDylation involves the activation of NEDD8 (catalysed by a heterodimeric E1-like enzyme, APP-BPI/Uba3), followed by NEDD8 transfer to UBC12, an E2-like enzyme, and subsequent NEDD8 conjugation to a target protein (Osaka et al., 1998; Gong and Yeh, 1999) . To date, members of the Cullin/Cdc53 family, which serve as core subunits of SCF and other Cullin-containing ubiquitin ligase complexes, are the only known proteins modified by NEDD8 (Hochstrasser, 2000) . NEDD8 conjugation promotes a conformational change of Cul-1 that may result in efficient formation of an E2-E3 complex (Kawakami et al., 2001; Wu et al., 2002) , thus stimulating SCF complexes activity (Morimoto et al., 2000; Read et al., 2000) . We have recently shown that NEDDylation is essential for SCF b-TrCP -mediated ubiquitination and processing of the p105 precursor (Amir et al., 2002) .
While it is clear that signal-induced processing of phosphorylated p100 is mediated by SCF b-TrCP , the resulting downstream molecular events involved in p100 ubiquitination and the role of NEDDylation have not been established. Here, we provide biochemical evidence that signal-induced ubiquitination and processing of p100 is site specific, involving a single lysine residue, K855. A similar lysine residue, K22, is shared by IkBa and possibly by other IkBs (Figure 1 ), but it does not exist in p105: ubiquitination of this protein by b-TrCP involves multiple lysine residues scattered along the entire C-terminal/degradable IkBg portion of the molecule (unpublished data). We also demonstrate that the NEDD8 pathway is essential for SCF b-TrCP -mediated ubiquitination and processing of phosphorylated p100. Our data emphasize the requirements for several control layers involved in p100 processing, and provide insight into the novel pathway regulating the inducible processing of the NF-kB2 precursor protein.
Results
Identification of lysine residue 855 as the major site of signal-induced, SCF b-TrCP -mediated p100 ubiquitination and processing in vitro Since the role of SCF b-TrCP -mediated processing of phosphorylated p100 has been only recently been established (Fong and Sun, 2002) , it was important to define the downstream biochemical events regulating this process. The SCF b-TrCP ligase complex recognizes and binds to a common phosphorylation site found in the IkB proteins (IkBa, IkBb and IkBe), b-catenin and HIV-Vpu (Figure 1 and Karin and Ben-Neriah, 2000) . Once phosphorylated, the SCF b-TrCP ligase ubiquitinates IkBa on two specific lysine residues, 21 and 22, that reside 10 residues upstream to its binding site in the molecule (Scherer et al., 1995; Baldi et al., 1996) . Since p100 shares this common IKK phosphorylation and E3 binding site (Ser 865, 869; Figure 1 ), we looked for adjacent lysine residues in the molecule in an attempt to identify a potential ubiquitin-anchoring site. There are three lysine residues flanking the phosphoacceptors site of p100, 855, 862 and 878. Using site-directed mutagenesis, we substituted each of these lysines, independently and sequentially, with arginine and tested the ability of the mutant proteins (Table 1) to be ubiquitinated and processed following phosphorylation. From analysis of the triple mutant K855/862/878R, the double mutant K862/878R, and the single mutant K855R in a cell-free reconstituted system, it is clear that only K855 plays a major role as an ubiquitination site of p100 (Figure 2a) . Similar results were obtained when the different mutants were tested for processing in crude extracts (Figure 2b and data not shown). It should be noted however that low, probably signal-independent, basal processing can be detected when the K855R mutant is employed (Figure 2b, lanes 3,4) , suggesting that while p100 is processed mostly following signaling, basal processing may also provide small amounts of p52 required under nonstimulated conditions. Taken together, our results demonstrate that removal of K855 blocks almost completely signal-induced and SCF b-TrCP -mediated Phosphoacceptors serine residues and ubiquitin-anchoring lysine residues are in bold face. It should be noted that only for IkBa and for p100, the marked lysine residues have been shown experimentally to serve as anchoring sites for the polyubiquitin chain p100 processing: site-specific ubiquitination and NEDD8 RE Amir et al ubiquitination and processing of p100, suggesting that this residue serves as the major ubiquitin-anchoring site during signal-induced processing.
Signal-induced, SCF
b-TrCP -mediated ubiquitination and processing of p100 in cells requires K855
Having established a role for lysine residue 855 in the cell-free assays, it was important to assess its requirement for p100 ubiquitination and processing in vivo. To that end, we transfected 293 cells with cDNAs coding for either wild type (WT) or one of the mutant p100 proteins, and compared their ability to be ubiquitinated and processed following NIK stimulation. In NIKexpressing cells, removal of lysine residue 855 inhibited significantly ubiquitination of p100 (Figure 3 , compare lane 3 to lane 1). It should be noted that in most experiments, it was difficult to detect NIK-induced conjugates of p100-WT unless a proteasome inhibitor was added (Figure 3 , compare lane 2 to lane 1). This is due, most probably, to the rapid degradation/processing of the precursor once it is ubiquitinated. It can also be due to rapid deubiquitination of the conjugates: following proteasome inhibition, some of them may remain bound to the proteasome and are therefore inaccessible to the action of the deubiquitinating enzymes. Not surprisingly, signal-induced processing of p100 in cells is also dependent to a large extent on K855. As can be clearly seen in Figure 4 , NIK expression results in almost complete disappearance of the p100-WT, accompanied by generation of the processed product p52 (compare lane 2 to lane 1). Similar to the WT protein, the two p100 mutants lacking either lysine residues 878 (K878R) or 878 and 862 (K867/878R) are also processed efficiently following NIK stimulation (compare lanes 4 and 6 to lane 2). As expected, removal of lysine 855 significantly inhibited NIK-induced p100 processing (compare lanes 8 and 10 to lanes 2, 4 and 6). Here too, inhibition was not complete, leaving behind some residual, yet signal-dependent, ubiquitination ( Figure 3 , lanes 3 and 4) and processing ( Figure 4 , compare lanes 9 and 10) that involves, most probably, a different Lys residue. This, yet unidentified, residue plays however a minor role in the process. At this point, we wanted to assess whether additional lysine residues residing upstream to position 855 also act as potential ubiquitin anchors. We therefore substituted lysine residue 743 and generated the following mutants: K743R, K743/855R and K743/855/862/878R). Removal of lysine 743 alone had no effect on NIK-induced p100 processing, while removal of lysine 743 together with lysine 855, resulted, as expected, in significant inhibition of both p100 ubiquitination and processing (data not shown). These in vivo studies correlate strongly with our in vitro findings, and provide further evidence that signalinduced and SCF b-TrCP -mediated p100 ubiquitination and processing involve specific ubiquitination at lysine residue 855.
b-TrCP -mediated ubiquitination and processing of p100 in a cell-free reconstituted system require the NEDD8 pathway
We have recently shown that the NEDD8 pathway is essential for SCF b-TrCP mediated ubiquitination and Phosphorylated serine residues and neighboring upstream lysine residue are in bold face -mediated processing of phosphorylated p100. Processing of labeled p100 was carried out in crude HeLa cell extract as described under Materials and methods. Points of migration of p100 and p52 are marked. Results presented in panel b were quantified, where 100% represents processing of the p100-WT. Numbers represent % inhibition relative to this value p100 processing: site-specific ubiquitination and NEDD8 RE Amir et al processing of p105 (Amir et al., 2002) . As the SCF b-TrCP ligase is involved in signal-induced processing of both the NF-kB1 and NF-kB2 precursor proteins, we wanted to investigate the role of NEDDylation of SCF b-TrCP -mediated ubiquitination and processing of p100, as well. As can be seen in Figure 5 , in a cell-free system reconstituted from purified recombinant enzymes, efficient ubiquitination of phosphorylated p100 requires the addition of all three components of the NEDD8 pathway, (APP-BPI/Uba3, UBC12, and NEDD8): the three 'canonical' ubiquitin conjugating enzymes, E1, UBCH5c, and SCF b-TrCP , are not sufficient to promote maximal conjugation of p100 (compare lane 2 to lane 3). The conjugation observed in the absence of exogenously added NEDDylating system (lane 2) is due, most probably, to the activity of components of the system present in the crude extract in which p100 was translated. In addition, it is possible that part of the Cul-1 in the SCF complex purified from insect cells is already NEDDylated. A mutant SCF b-TrCP containing K696R Cul-1 (a point mutant Cul-1 in which lysine 696 is substituted with arginine, and therefore cannot be conjugated to NEDD8; Morimoto et al., 2000) fails to ubiquitinate phosphorylated p100 (lane 4). It probably replaces the WT Cullin component in the SCF complex, and therefore inhibits conjugation completely. Obviously, the NEDDylation system in the crude extract mediated processing of p100 in vivo. cDNAs coding for either WT or one of the indicated p100 lysine mutants were transfected into HEK 293 cells along with a cDNA coding for NIK as indicated. After 24 h cells were harvested and lysed, and processing of p100 to p52 was monitored using Western blot analysis as described under Materials and methods Figure 5 Ubiquitination of p100 by SCF b-TrCP requires phosphorylation followed by NEDDylation. In vitro translated and 35 S[methionine]-labeled p100 was phosphorylated, immunoprecipitated, and subjected to ubiquitination (lanes 1-4) as described under Materials and methods. Parallel samples were incubated with nonphosphorylated p100 (lanes 5-8) . WT or Cul-1 K696R SCF b-TrCP complexes, as well as all three components of the NEDD8 pathway (the E1 APP-BPI/Uba3, the E2 UBC12, and NEDD8) were added as indicated. Points of migration of p100 and p100-ubiquitin adducts (Conj.) are marked Figure 3 Lysine 855 is required for signal-induced, SCF b-TrCPmediated p100 ubiquitination in vivo. cDNAs coding for either WT or K855R mutant p100 were transfected into HEK 293 cells as indicated along with cDNAs coding for NIK and HA-ubiquitin. After 48 h, MG132 was added as indicated and following additional 3 h cells were harvested and lysed as described under Materials and methods. Following immunoprecipitation (IP) with a-p100 antibody, ubiquitin conjugates were detected via Western blot (IB) using a-HA antibody (upper panel) as described under Materials and methods. An aliquot from each sample was blotted with a-p100 antibody (lower panel) p100 processing: site-specific ubiquitination and NEDD8 RE Amir et al cannot NEDDylate it. As expected, Cul-1 NEDDylation of SCF b-TrCP is linked to p100 phosphorylation, and nonphosphorylated p100 cannot be conjugated (lanes 5-8). To further dissect the requirements for NEDD8 modification in p100 ubiquitination, we studied the effect of a dominant negative (DN) UBC12 (a point mutant UBC12 in which the active-site cysteine residue 111 was substituted with serine (Amir et al., 2002) on p100 conjugation and processing. In crude HeLa cell extract, ubiquitin conjugation and processing of phosphorylated p100 was markedly decreased by the addition of the DN-UBC12 (Figure 6a Figure 7a , lane 3). Also, the DN enzymes compete with, but do not completely inhibit, their endogenous WT counterparts. As expected, a mutant p100 (p100SS/AA, see Table 1 ), which cannot be phosphorylated and therefore cannot be recognized by b-TrCP, could still be conjugated and processed although to a significantly lower extent, but its conjugation and processing were not affected at all by the addition of the DN-UBC12 (Figure 6b , compare lane 2 to lane 3; Figure 7b , compare lane 2 to lane 3). In the experiments described in Figures 6 and 7 , the NEDD8 pathway components were provided by the wheat germ cell extract in which p100 was translated and by the HeLa cell extracts in which the assays were carried out. The cell extracts contain sufficient amount of NEDD8 and all its conjugating enzymes, and addition of exogenous WT-UBC12 does not stimulate ubiquitination any further (Figure 6a , compare lane 3 to lane 2). Our results demonstrate that the NEDD8 pathway is required for efficient activity of the SCF b-TrCP ligase towards phosphorylated p100. Blockade of the pathway by either a DN-UBC12 or a mutant Cul-1 results in marked inhibition of this activity, suggesting an essential role for NEDDylation in signal-induced p100 ubiquitination and processing.
NEDD8 pathway is required for signal-induced, SCF
b-TrCP -mediated processing of p100 in vivo
We next investigated the role of the NEDD8 pathway in vivo. As processing of p100 is low under basal conditions and is mostly signal-induced , and given that SCF b-TrCP mediates only stimulated processing (Fong and Sun, 2002) , we studied the role of NEDDylation on p100 processing either in the presence or absence of an upstream signal. First, we corroborated the role of bTrCP in the process. As can be seen in Figure 8a , in NIK-expressing 293 cells, processing of p100 is stimulated significantly: almost no processing can be observed in cells that do not express NIK (compare lane 2 to lane 1). Suppression of b-TrCP by siRNA inhibited p100 processing almost completely (lane 3) resulting in accumulation of the precursor protein p100 (compare lane 3 to lane 2). The efficiency of b-TrCP gene suppression was monitored by Real Time PCR: specific RNA levels were decreased by 88% compared to expression of an irrelevant mRNA. DF-box b-TrCP acts as a DN inactive ligase: it can bind the substrate but not the Skp1 component, and therefore cannot recruit the E2 enzyme. Consequently, the bound substrate is Figure 7 p100 processing is inhibited by a DN-UBC12 (C111S) . Processing of labeled p100 was carried out in crude HeLa cell extract as described under Materials and methods. (a) DN (C111S) UBC12 inhibits p100 processing, and inhibition is alleviated by excess WT-UBC12. WT-UBC12 and DN-UBC12 were added at 1.2 and 3.6 mg, respectively, as indicated. Results presented in panel a were quantified, where 100% represents processing in the crude extract in the absence of added UBC12. Numbers represent % inhibition relative to this value. (b): Processing of p100 that lacks the b-TrCP binding site is not affected by DN-UBC12. WT-and DN-UBC12 were added at 1.2 and 3.6 mg, respectively, as indicated. Points of migration of p100 and p52 are marked Figure 6 A catalytic site mutant UBC12 (C111S) exerts a DN effect on p100 ubiquitination. In vitro translated and 35 S[methionine]-labeled p100 was phosphorylated and ubiquitinated in crude HeLa cell extract as described under Materials and methods. All the enzymatic components were provided by the crude wheat germ and HeLa extracts, and the different E2 enzymes were added as indicated. (a): Mutant UBC12 (C111S) inhibits ubiquitination of p100, and inhibition is alleviated by excess of the WT enzyme. WT (1.2 mg) and DN-UBC12 (3.6 mg) were added as indicated. (b) Ubiquitination of p100 that lacks the b-TrCP binding site is not affected by DN-UBC12. WT-and DN-UBC12 were added at 1.2 and 3.6 mg, respectively, as indicated. The p100 protein used in this experiment lacks the b-TrCP binding site (p100SS/AA, see Table 1 ). Points of migration of p100 as well as of p100-ubiquitin adducts (Conj.) are marked . This is due to the effect of the competing endogenous WT components, but also to the fact that the NEDD8 pathway is required only for signal-induced and SCF b-TrCP -mediated processing of p100, and does not affect the basal, signalindependent process.
Discussion
Processing of the nfkb1 and nfkb2 gene products p105 and p100 to generate the active subunits p50 and p52, respectively, are exceptional events in which the ubiquitin system is involved in limited processing rather than in complete destruction of its target substrates. Processing of p100 is tightly regulated via a novel pathway mediated by NIK and the downstream IKKa (Xiao et al., 2001; Senftleben et al., 2001) . Once phosphorylated at the C-terminal region, p100 is ubiquitinated by SCF b-TrCP and undergoes proteasomal processing (Fong and Sun, 2002) . In the present study, we further elucidated the mechanism of SCF b-TrCP -mediated p100 ubiquitination and processing. Importantly, we provide strong evidence that SCF b-TrCP -mediated p100 ubiquitination is site specific and occurs, most probably, on lysine 855. Substitution of K855 significantly inhibited ubiquitination and processing of phosphorylated p100 by SCF b-TrCP in a cell-free reconstituted system in vitro (Figure 2) . Similar confirming results were obtained in intact cells (Figures 3 and 4) . Taken together, we conclude that K855 serves as the major ubiquitin-anchoring site used for signal-induced p100 ubiquitination and processing. It should be noted however, that only for a handful of substrates, it has been shown directly, using mass spectrometric analysis, that the Lys residue(s) studied serves as an anchor for the polyubiquitin chain. In all other cases, and they are not too many either, the conclusion that the chain is anchored to a specific Lys is based on mutational analysis. This residue can be involved, for example, in recognition of the substrate by the E3, but ubiquitination occurs elsewhere in the molecule. We also found that efficient SCF b-TrCP -mediated ubiquitination of phosphorylated p100 requires the presence of all components of the NEDD8 pathway: APP-BPI/Uba3, UBC12 and NEDD8 ( Figure 5 ). Consistent with these results, inhibition of the NEDD8 pathway by either a mutant Cul-1 (K696R) (Figure 5 ) or a DN-UBC12 (Figures 6  and 7) , significantly inhibited ubiquitin conjugation and processing of phosphorylated p100. Finally, expression of the DN proteins in cells confirmed the in vitro findings (Figure 8 ), enabling us to conclude that the NEDD8 pathway is required for signal-induced and SCF b-TrCP -mediated p100 ubiquitination and processing.
Interestingly, ubiquitination of p100 is similar to that of IkBa: both proteins share not only the same IKK phosphorylation and SCF b-TrCP -binding site, but also similar ubiquitination site. IkBa is ubiquitinated on lysines residues 21 and 22, where K22 resides 10 residues upstream to the first phosphoacceptor site, serine 32. Similarly, p100 is ubiquitinated on lysine 855, which resides in the same distance from the first phosphoacceptor site, serine 865. Nevertheless, the mechanism of p100 processing differs from that regulating IkBa degradation. While NIK plays an essential role in regulating p100 processing , it is not required for cytokine-induced degradation of IkBa (Shinkura et al., 1999) . Furthermore, IKKb, which is essential for activation of the canonical NF-kB signaling pathway, is dispensable for NIK-induced p100 processing, while IKKa is an essential component of this pathway (Senftleben et al., 2001) .
Specific ubiquitination sites do not usually play a role in targeting substrates to the ubiquitin system, where often multiple sites of ubiquitination exist and single mutations have no or little effect on protein degradation. In the homologous 'sister' molecule, p105, where such a specific lysine residue does not exist, substitution of all 30 residues in the C-terminal IkBg degradable b-TrCP is essential for signal-induced p100 processing. cDNAs coding for p100, NIK and DF-box human b-TrCP1, or oligonucleotides for silencing (siRNA) of b-TrCP 1 and 2 were transfected into HEK 293 cells as indicated, and processing of p100 to p52 was monitored using Western blot analysis as described under Materials and methods. (b) DN-UBC12 and DN-Cul1(K696R) inhibit NIK-induced processing of p100. cDNAs coding for p100, NIK, DN-UBC12 and DN-Cul1(K696R) were transfected into HEK 293 cells as indicated. After 24 h, cells were harvested and lysed, and processing of p100 was monitored using Western blot analysis as described under Materials and methods. Results presented in panels a and b were quantified, where 100% represents processing of p100 in NIKexpressing cells in the absence of any other modulator. Numbers represent % inhibition relative to this value p100 processing: site-specific ubiquitination and NEDD8 RE Amir et al domain of the molecule was necessary to inhibit completely IKKb-and b-TrCP-induced degradation of the molecule (unpublished data). Why is it then that ubiquitination is specifically directed to lysine 855 of p100? How can the same TrCP ligase ubiquitinates different lysine residues once bound to similar phosphoserine residues? One possibility is that when such lysine exists, it serves as an efficient and accessible ubiquitination site. In p105, a similar residue does not exist. In p100, lysines residues 862 and 878 may reside too close to the phosphorylation and binding site of SCF b-TrCP , which may render them inaccessible for ubiquitination. Obviously, this scenario is similar to that of IkBa where there are no other lysine residues except for K21 and K22 that reside close and upstream to the phosphorylation site, and are therefore the only ones accessible for ubiquitination. This hypothesis can be now tested in the case of p105 by inserting an appropriate lysine residue upstream to the phosphorylation site in the right distance. It is expected that following signalling such a p105 molecule will be processed and not degraded. The fact that such a specific lysine residue exists and serves as a major ubiquitation site may render p100 resistant to TrCP-mediated degradation, while p105 is degraded following ubiquitination on its multiple lysine residues. Since p105 and not p100 acts also as an NF-kB inhibitor that must be removed, this particular structure makes a biological sense.
Processing of p100 is mostly signal-induced due to the presence of a C-terminal PID-containing DD . Dysregulated constitutive processing of p100 has deleterious effects: chromosomal translocation of the nfkb2 gene that results in the loss of the Cterminal PID has been observed in a number of B-and T-cell lymphomas and leukemias (Neri et al., 1991; Neri et al., 1996) . Thus, a tight control of p52 levels in the cells is required and can be accomplished by a unique regulated pathway involving signaling, NIK activation, IKKa-mediated phosphorylation and SCF b-TrCP -mediated specific ubiquitination that follows activation of the ligase by NEDD8. Our studies provide evidence for the role of NEDDylation and specific rather then random ubiquitination. This signaling pathway becomes even further elaborated since the NEDD8 pathway is regulated itself by tuning of NEDD8 modification (Read et al., 2000; Kawakami et al., 2001) , downregulation of NEDD8 (Kamitani et al., 2001 ) and regulated deNEDDylation (Gong et al., 2000; Lyapina et al., 2001; Schwechheimer et al., 2001 ).
Materials and methods

Plasmids and construction of mutants
WT human p100 cDNAs used for in vitro translation (pSP64) and for transient transfection (pCS2) were described previously (Senftleben et al., 2001; Xiao et al., 2001) . cDNA encoding for NIK was described previously (Senftleben et al., 2001; Xiao et al., 2001) . All K-to-R and S-to-A substitutions were generated by site-directed mutagenesis using the QuickChanget kit. Each substitution was designated according to the residue number along the protein (see Table 1 ). h-b-TrCP1, Skp1 and Rbx1/Roc1/Hrt1 cDNAs for expression of proteins in insect cells and cDNA for expression of h-DF-box b-TrCP1 (DF-b-TrCP1) in mammalian cell were as described (Orian et al., 2000) . cDNAs coding for WT and for DN-UBC12 (C111S) for mammalian cell and bacterial expression were as described previously (Amir et al., 2002) . cDNAs coding for WT Cul-1 and for Cul-1(K696R) for both mammalian cell expression and for expression of the proteins in insect cells were as described (Kawakami et al., 2001) . cDNA coding for His-NEDD8 for bacterial expression in pT7-7 and for the NEDD8 E1 heterodimeric APP-BPI/T7-Uba3 complex were described previously (Kawakami et al., 2001; Amir et al., 2002) .
Preparation of recombinant proteins
Generation of tetrameric His-TrCP1-containing SCF complexes (h-b-TrCP1Skp1WT or K696R Cul-1Rbx1/Roc1/ Hrt1) and heterodimeric His-h-APP-BPI/T7-Uba3 complex from baculoviruse-infected Hi-5 insect cells was described previously (Amir et al., 2002) .
Transient transfections and processing of p100 in cells 293 cells were transiently transfected with 1.5 mg of a cDNA coding for the WT or one of the mutant p100s. When indicated, cells were cotransfected with B1.5 mg of each of the cDNAs coding for NIK and either WT-UBC12, DN-UBC12C111S or Cul-1 K696R. An empty vector was added when necessary to maintain an equal amount of DNA in all transfections. Transfections were carried out using the Fugenet reagent. At 24-48 h after transfection, cells were harvested and lysed in RIPA buffer (150 mM NaCl, 0.5% DOC, 50 mM Tris pH 7.6, 0.1% SDS and protease inhibitors mixture). Equal amounts of protein were resolved via SDS-PAGE (10%) and blotted onto nitrocellulose paper. Processing of p100 was monitored by Western blot analysis using ap52 antibody and ECL.
In vitro ubiquitination and processing of p100
In vitro ubiquitination and processing of p100 were assayed in crude HeLa extract as described (Amir et al., 2002) .
Detection of ubiquitin conjugates in cells
293 cells were transiently transfected with cDNAs coding for either WT-or mutant p100 along with expression vectors coding for NIK and HA-Ubiquitin. At 24 h after transfection, the proteasome inhibitor MG132 was added for 3 h as indicated. Cells were harvested and lysed in a buffer (heated to 951C) containing 1% SDS, 1 mM EDTA and protease inhibitors mixture (in PBS), and subjected to immunoprecipitation (IP) using a-p100. The Protein A agarose beads were washed twice with a buffer containing 2% TX100, 0.5% DOC, 1% BSA and protease inhibitors mixture (in PBS), followed by two washes with PBS, and the bound proteins were eluted with SDS loading buffer. The eluted ubiquitin-conjugated p100 was detected by immunoblotting (IB) using a-HA.
siRNA silencing of b-TrCP Double-stranded siRNA to silence human b-TrCP1 and 2 was as described . The siRNA oligonucleotides sequences are: GUG GAA UUU GUG GAA CAU CTT (sense) and GAU GUU CCA CAA AUU CCA CTT (antisense). Transfection of 293 cells with the siRNA p100 processing: site-specific ubiquitination and NEDD8 RE Amir et al oligonucleotides was performed as previously described . The efficacy of b-TrCP gene suppression was monitored by Real Time PCR.
